19-49835536-G-C

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1

The NM_030973.4(MED25):​c.1677G>C​(p.Met559Ile) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00013 in 1,557,508 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Uncertain significance in ClinVar.

Frequency

Genomes: 𝑓 0.00043 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000097 ( 0 hom. )

Consequence

MED25
NM_030973.4 missense, splice_region

Scores

3
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:1

Conservation

PhyloP100: 1.93

Publications

1 publications found
Variant links:
Genes affected
MED25 (HGNC:28845): (mediator complex subunit 25) This gene encodes a component of the transcriptional coactivator complex termed the Mediator complex. This complex is required for transcription of most RNA polymerase II-dependent genes. The encoded protein plays a role in chromatin modification and in preinitiation complex assembly. Mutations in this gene are associated with Charcot-Marie-Tooth disease type 2B2. [provided by RefSeq, Apr 2010]
MED25 Gene-Disease associations (from GenCC):
  • congenital cataract-microcephaly-nevus flammeus simplex-severe intellectual disability syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • autosomal recessive non-syndromic intellectual disability
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Charcot-Marie-Tooth disease type 2B2
    Inheritance: AR Classification: SUPPORTIVE, NO_KNOWN Submitted by: Orphanet, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.013620943).
BP6
Variant 19-49835536-G-C is Benign according to our data. Variant chr19-49835536-G-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 476802.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000433 (66/152304) while in subpopulation AFR AF = 0.0014 (58/41566). AF 95% confidence interval is 0.00111. There are 0 homozygotes in GnomAd4. There are 41 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_030973.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MED25
NM_030973.4
MANE Select
c.1677G>Cp.Met559Ile
missense splice_region
Exon 15 of 18NP_112235.2
MED25
NM_001378355.1
c.1677G>Cp.Met559Ile
missense splice_region
Exon 15 of 18NP_001365284.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MED25
ENST00000312865.10
TSL:1 MANE Select
c.1677G>Cp.Met559Ile
missense splice_region
Exon 15 of 18ENSP00000326767.5
MED25
ENST00000538643.5
TSL:1
c.1038G>Cp.Met346Ile
missense splice_region
Exon 10 of 13ENSP00000437496.1
MED25
ENST00000594998.1
TSL:1
n.2297G>C
splice_region non_coding_transcript_exon
Exon 2 of 4

Frequencies

GnomAD3 genomes
AF:
0.000434
AC:
66
AN:
152186
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00140
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000393
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000118
AC:
20
AN:
168864
AF XY:
0.0000552
show subpopulations
Gnomad AFR exome
AF:
0.00138
Gnomad AMR exome
AF:
0.0000754
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000590
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000975
AC:
137
AN:
1405204
Hom.:
0
Cov.:
33
AF XY:
0.0000922
AC XY:
64
AN XY:
694026
show subpopulations
African (AFR)
AF:
0.00263
AC:
84
AN:
31972
American (AMR)
AF:
0.000133
AC:
5
AN:
37528
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24922
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36694
South Asian (SAS)
AF:
0.0000251
AC:
2
AN:
79602
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
48826
Middle Eastern (MID)
AF:
0.000460
AC:
2
AN:
4344
European-Non Finnish (NFE)
AF:
0.0000194
AC:
21
AN:
1083334
Other (OTH)
AF:
0.000397
AC:
23
AN:
57982
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
9
18
26
35
44
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000433
AC:
66
AN:
152304
Hom.:
0
Cov.:
32
AF XY:
0.000551
AC XY:
41
AN XY:
74462
show subpopulations
African (AFR)
AF:
0.00140
AC:
58
AN:
41566
American (AMR)
AF:
0.000392
AC:
6
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5170
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68022
Other (OTH)
AF:
0.000473
AC:
1
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
4
8
11
15
19
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000284
Hom.:
0
Bravo
AF:
0.000593
ESP6500AA
AF:
0.00115
AC:
5
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000144
AC:
17
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:not provided

Jan 20, 2024
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

See Variant Classification Assertion Criteria.

Charcot-Marie-Tooth disease Uncertain:1
Molecular Genetics Laboratory, London Health Sciences Centre
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Charcot-Marie-Tooth disease type 2 Uncertain:1
Aug 07, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces methionine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 559 of the MED25 protein (p.Met559Ile). This variant is present in population databases (rs369006637, gnomAD 0.1%). This missense change has been observed in individual(s) with clinical features of Charcot-Marie-Tooth disease (PMID: 32376792). ClinVar contains an entry for this variant (Variation ID: 476802). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The isoleucine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.31
T
BayesDel_noAF
Benign
-0.25
CADD
Benign
22
DANN
Benign
0.96
DEOGEN2
Benign
0.085
T
Eigen
Benign
-0.28
Eigen_PC
Benign
-0.17
FATHMM_MKL
Benign
0.71
D
LIST_S2
Benign
0.72
T
M_CAP
Uncertain
0.23
D
MetaRNN
Benign
0.014
T
MetaSVM
Benign
-0.75
T
MutationAssessor
Benign
1.5
L
PhyloP100
1.9
PrimateAI
Uncertain
0.64
T
PROVEAN
Benign
-0.81
N
REVEL
Benign
0.20
Sift
Uncertain
0.023
D
Sift4G
Benign
0.31
T
Polyphen
0.0010
B
Vest4
0.31
MutPred
0.43
Gain of loop (P = 0.0166)
MVP
0.65
MPC
0.20
ClinPred
0.030
T
GERP RS
2.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.11
gMVP
0.25
Mutation Taster
=87/13
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs369006637; hg19: chr19-50338793; API